Close

Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $50 at Citi

October 3, 2022 6:24 AM EDT Send to a Friend
Citi analyst Neena Bitritto-Garg raised the price target on Amylyx Pharmaceuticals inc. (NASDAQ: AMLX) to $50.00 (from $48.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login